
Cardiovascular risk, read from a photograph of the retina.
FutureMedics is Mediwhale’s distribution partner in Switzerland. Together with Eyro, we bring the retina AI scan to clinics, health checks and companies: a 30-second photograph of the retina, a CE-marked AI reading and a report signed by the clinic’s own clinicians.
Medical innovations
Retina AI scan with Dr. Noon by Mediwhale, VO₂max with VentriJect, SmartCardia and HeartForce.
Dr. Noon by Mediwhale
Dr. Noon CVD is Mediwhale’s retina-based AI for cardiovascular risk assessment, CE-marked as a Class IIa medical device. FutureMedics is Mediwhale’s distribution partner in Switzerland and introduces Dr. Noon to longevity centres, metabolic health centres and preventive healthcare centres.
In partnership with Eyro
Eyro operates the retina scan stations, the reporting and the scan network in the Netherlands and Switzerland. FutureMedics and Eyro carry out scans together at health checks and company events.
FormMed Health Day, Zürich




